Cumberland Pharmaceuticals (CPIX) Assets (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Assets across 17 years of filings, most recently posting $71.0 million for Q1 2026.

• Assets for Q1 2026 came in at $71.0 million, up 1.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.0 million (up 1.51% YoY), and the FY2025 annual result was $76.8 million, up 1.64% from the prior year.
• Assets came in at $71.0 million for Q1 2026 at Cumberland Pharmaceuticals, down from $76.8 million in the prior quarter.
• In the past five years, Assets ranged from a high of $96.7 million in Q1 2022 to a low of $65.9 million in Q3 2025.
• The 5-year median for Assets is $81.5 million (2024), against an average of $81.5 million.
• Across the five-year window, Assets advanced 10.02% in 2022 and dropped 14.2% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Assets stood at $92.9 million in 2022, then declined by 12.0% to $81.8 million in 2023, then slipped by 7.57% to $75.6 million in 2024, then grew by 1.64% to $76.8 million in 2025, then retreated by 7.59% to $71.0 million in 2026.
• The last three Assets figures came in at $71.0 million (Q1 2026), $76.8 million (Q4 2025), and $65.9 million (Q3 2025), per Business Quant data.